Amyloid properties of the leader peptide of variant B cystatin C: implications for Alzheimer and macular degeneration

FEBS Lett. 2016 Mar;590(5):644-54. doi: 10.1002/1873-3468.12093. Epub 2016 Feb 26.

Abstract

Variant B (VB) of cystatin C has a mutation in its signal peptide (A25T), which interferes with its processing leading to reduced secretion and partial retention in the vicinity of the mitochondria. There are genetic evidences of the association of VB with Alzheimer's disease (AD) and age-related macular degeneration (AMD). Here, we investigated aggregation and amyloid propensities of unprocessed VB combining computational and in vitro studies. Aggregation predictors revealed the presence of four aggregation-prone regions, with a strong one at the level of the signal peptide, which indeed formed toxic aggregates and mature amyloid fibrils in solution. In light of these results, we propose for the first time the role of the signal peptide in pathogenesis of AD and AMD.

Keywords: Alzheimers' disease and exudative age-related macular degeneration; human cystatin C; protein aggregation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amino Acid Sequence
  • Amyloidogenic Proteins / chemistry*
  • Computational Biology
  • Cystatin C / chemistry*
  • Humans
  • Macular Degeneration / metabolism*
  • Molecular Sequence Data
  • Protein Aggregates
  • Protein Sorting Signals*
  • Protein Structure, Secondary
  • Risk

Substances

  • Amyloidogenic Proteins
  • Cystatin C
  • Protein Aggregates
  • Protein Sorting Signals